5.4 Hz, 1H), 4.34 (dd, J = 12.0, 2.9 Hz, 1H), 3.74 (dddd,
J = 8.6, 8.6, 5.7, 1.2 Hz, 1H), 3.55 (dq, J = 9.5, 7.2 Hz, 1H),
3.31 (dq, J = 9.5, 7.2 Hz, 1H), 2.45-2.42 (m, 2H), 2.10 (dddd,
J = 14.5, 12.9, 5.7, 5.7 Hz, 1H), 1.99-1.93 (m, 1H), 1.80-1.74
(m, 1H), 1.71-1.47 (m, 3H), 1.15 (dd, J = 7.2, 7.2 Hz, 3H);
13C NMR (125 MHz, CDCl3) δ 144.5 (C), 128.3 (CH), 127.4
(CH), 126.9 (CH), 106.7 (CH), 65.4 (CH), 64.4 (CH2), 60.7
(CH), 38.6 (CH2), 35.2 (CH2), 25.5 (CH2), 19.3 (CH2), 15.2
(CH3); HRMS (ESI), calcd for C15H21NO2Na+ (M+Na)+
270.1470, found 270.1469.
1-((tert-Butyldimethylsilyl)oxy)-5-vinylpyrrolidin-2-one
(31): A solution of N-siloxyamide 30 (330 mg, 1.04 mmol)
and CH2Cl2 (42 mL) was degassed using the freeze-pump-thaw
technique (3©). The solution was transferred to a flask charged
with Pd(PPh3)4 (24.0 mg, 20.8 ¯mol) at room temperature,
maintained for 9 h at room temperature, and concentrated. The
residue was purified by silica column chromatography (EtOAc/
hexane 1:8) to give 251 mg of N-siloxylactam 31 (100%): a
colorless oil; IR (film) 2956, 2931, 2859, 1728, 1250, 837,
1
786 cm¹1; H NMR (500 MHz, CDCl3) δ 5.76 (ddd, J = 17.2,
N-((tert-Butyldimethylsilyl)oxy)pent-4-enamide (29): N-
Methylmorpholine (720 ¯l, 6.5 mmol) was added to a solution
of carboxylic acid 28 (510 ¯L, 5.0 mmol) and Et2O (15 mL) at
0 °C. After cooling to 0 °C, ethyl chloroformate (570 ¯L, 6.0
mmol) was then added to the solution. The resulting sus-
pension was stirred for 1.5 h at 0 °C, added to a solution of
O-(tert-butyldimethylsilyl)hydroxylamine (1.10 g, 7.50 mmol)
and Et2O (7.0 mL) at 0 °C, and allowed to warm to room
temperature. After stirring for 4.5 h at room temperature, the
solution was concentrated. The residue was purified by silica
gel column chromatography (EtOAc/hexane 1:15 to 1:10) to
give 1.15 g of N-siloxyamide 29 (100%): white crystals; mp
57.1-58.0 °C; IR (film) 3159, 2961, 2859, 1655, 1259, 1247,
984, 834, 787 cm¹1; 1H NMR (500 MHz, CDCl3, 60 °C, a 5.5:1
mixture of two rotamers, Peaks of the major rotamer are report-
ed.) δ 7.42 (brs, 1H), 5.89-5.79 (m, 1H), 5.09 (d, J = 16.9 Hz,
1H), 5.03 (d, J = 10.6 Hz, 1H), 2.40 (td, J = 7.2, 7.2 Hz, 2H),
2.38-2.22 (m, 2H), 0.97 (s, 9H), 0.19 (s, 6H); 13C NMR (125
MHz, CDCl3, 60 °C, a mixture of two rotamers, Peaks of the
major rotamer were reported.) δ 161.9 (C), 137.0 (CH), 115.7
(CH2), 32.4 (CH2), 29.1 (CH2), 26.0 (CH3), 26.0 (CH3), 18.2
(C), ¹5.5 (CH3); HRMS (ESI), calcd for C11H24NO2Si+
(M+H)+ 230.1576, found 230.1570.
10.3, 8.0 Hz, 1H), 5.30 (ddd, J = 17.2, 0.9, 0.9 Hz, 1H), 5.24
(ddd, J = 10.3, 0.9, 0.9 Hz, 1H), 4.05 (ddddd, J = 8.0, 7.5, 6.3,
0.9, 0.9 Hz, 1H), 2.37 (ddd, J = 16.9, 9.7, 5.7 Hz, 1H), 2.29
(ddd, J = 16.9, 9.5, 6.3 Hz, 1H), 2.20 (dddd, J = 12.0, 9.5, 7.5,
5.7 Hz, 1H), 1.79 (dddd, J = 12.0, 9.7, 6.3, 6.3 Hz, 1H), 0.95
(s, 9H), 0.22 (s, 3H), 0.21 (s, 3H); 13C NMR (125 MHz, CDCl3)
δ 171.5 (C), 136.7 (CH), 118.9 (CH2), 63.3 (CH), 26.8 (CH2),
25.9 (CH3), 22.7 (CH2), 18.3 (C), ¹4.3 (CH3), ¹4.5 (CH3);
HRMS (ESI), calcd for C12H24NO2Si+ (M+H)+ 242.1576,
found 242.1579.
Dimethyl 6-vinylhexahydropyrrolo[1,2-b]isoxazole-2,3-
dicarboxylates (33 and 34): Zirconocene chloride hydride
(46.9 mg, 182 ¯mol) was added to a solution of N-siloxylactam
31 (29.1 mg, 121 ¯mol) and (CH2Cl)2 (1.5 mL) at room tem-
perature. After stirring for 1 h at room temperature, dimethyl
maleate (150 ¯L, 1.4 mmol) was added to the solution. This
solution was then heated to 40 °C, stirred for 5.5 h at 40 °C,
and cooled to room temperature. The resulting solution was
quenched with saturated aqueous NaHCO3 (2 mL), and extract-
ed with EtOAc (2 © 7 mL). The combined organic extracts were
dried over Na2SO4, and concentrated. The residue was purified
by silica gel column chromatography (EtOAc/hexane 1:1)
and subsequent preparative thin layer chromatography (EtOAc/
hexane 1:1) to give 19.8 mg of a mixture of isoxazolidines
33 and 34 (64%). For analytical samples, the diastereomeric
mixture was separated by HPLC (PEGASIL Silica 120-5, 250 ©
20 mm, Et2O/hexane 2.5:1, 10 mL/min, isoxazolidine 33: TR =
15.8 min, isoxazolidine 34: TR = 23.9 min). Isoxazolidine 33:
white crystals; mp 81.1-81.9 °C; IR (film) 2956, 2922, 1746,
1438, 1220 cm¹1; 1H NMR (500 MHz, CDCl3) δ 5.84 (ddd, J =
17.2, 10.3, 6.6 Hz, 1H), 5.23 (ddd, J = 17.2, 1.4, 1.4 Hz, 1H),
5.12 (ddd, J = 10.3, 1.4, 1.4 Hz, 1H), 4.91 (d, J = 7.7 Hz, 1H),
4.18 (ddd, J = 7.7, 7.7, 4.6 Hz, 1H), 3.75 (s, 3H), 3.71 (s, 3H),
3.58 (ddddd, J = 6.9, 6.6, 6.3, 1.4, 1.4 Hz, 1H), 3.39 (dd, J =
7.7, 7.7 Hz, 1H), 2.20 (dddd, J = 12.0, 8.3, 8.3, 7.7 Hz, 1H),
2.07 (dddd, J = 11.5, 11.5, 8.3, 6.3 Hz, 1H), 1.79-1.69 (m, 2H);
13C NMR (125 MHz, CDCl3) δ 169.9 (C), 169.5 (C), 137.9
(CH), 116.7 (CH2), 78.3 (CH), 69.6 (CH), 66.3 (CH), 57.1 (CH),
52.63 (CH3), 52.57 (CH3), 29.6 (CH2), 28.2 (CH2); HRMS
(E)-6-(((tert-Butyldimethylsilyl)oxy)amino)-6-oxohex-2-
en-1-yl Methyl Carbonate (30): A solution of (Z)-but-2-ene-
1,4-diyl dimethyl dicarbonate5 (2.3 mL) and CH2Cl2 (58 mL)
was refluxed for 2 h. N-Siloxyamide 29 (600 mg, 2.62 mmol)
and 2nd generation Hoveyda-Grubbs catalyst (32.7 mg, 52.4
¯mol) were added to the solution. This solution was heated to
reflux, and stirred for 18 h at that temperature. This solution
was quenched with a solution of potassium 2-isocyanoacetate6
(64.5 mg, 524 ¯mol) and MeOH (2 mL) at room temperature,
stirred for 30 min, and diluted with brine (20 mL). The mixture
was extracted with CH2Cl2 (2 © 20 mL). The combined organic
extracts were dried over Na2SO4, and concentrated. The residue
was purified by silica column chromatography (EtOAc/hexane
1:1) to give 759 mg of N-siloxyamide 30 (91%): a colorless oil;
IR (film) 3186, 2958, 2932, 2859, 1751, 1659, 1444, 1270,
1
836, 790 cm¹1; H NMR (500 MHz, CDCl3, 60 °C, a 6:1 mix-
+
ture of two rotamers, Peaks of the major rotamer are reported.)
δ 7.45 (brs, 1H), 5.83 (dt, J = 15.8, 6.9 Hz, 1H), 5.66 (dt, J =
15.8, 6.3 Hz, 1H), 4.57 (d, J = 6.3 Hz, 2 H), 3.78 (s, 3H), 2.42
(td, J = 6.9, 6.9 Hz, 2H), 2.32-2.18 (m, 2H), 0.98 (s, 9H), 0.19
(s, 6H); 13C NMR (125 MHz, CDCl3, 60 °C, a mixture of two
rotamers, Peaks of the major rotamer are reported.) δ 161.5 (C),
155.8 (C), 134.8 (CH), 124.9 (CH), 68.3 (CH2), 54.7 (CH3),
32.3 (CH2), 27.6 (CH2), 25.9 (CH3), 18.2 (C), ¹5.6 (CH3);
HRMS (ESI), calcd for C14H27NO5NaSi+ (M+Na)+ 340.1556,
found 340.1557.
(ESI), calcd for C12H18NO5 (M+H)+ 256.1185, found
256.1179. Isoxazolidine 34: a colorless oil; IR (film) 2954,
1
2924, 2852, 1741, 1438, 1207, 1177, 922, 733 cm¹1; H NMR
(500 MHz, CDCl3) δ 5.80 (ddd, J = 17.3, 10.5, 6.4 Hz, 1H),
5.25 (ddd, J = 17.3, 1.4, 1.4 Hz, 1H), 5.13 (ddd, J = 10.5, 1.4,
1.4 Hz, 1H), 4.72 (d, J = 8.2 Hz, 1H), 4.15 (ddddd, J = 9.5, 9.5,
6.4, 1.4, 1.4 Hz, 1H), 4.01 (ddd, J = 8.2, 8.2, 8.2 Hz, 1H), 3.95
(dd, J = 8.2, 8.2 Hz, 1H), 3.77 (s, 3H), 3.70 (s, 3H), 2.27 (dddd,
J = 15.3, 9.5, 9.5, 6.2 Hz, 1H), 1.90-1.79 (m, 2H), 1.71 (dddd,
J = 15.3, 9.5, 9.5, 9.5, 1H); 13C NMR (125 MHz, CDCl3)
© 2017 The Chemical Society of Japan